Castiglione, Juan Ignacio; Rivero, Alberto Daniel; Barroso, Fabio Adrián; Brand, Patricio; Lautre, Andrea Rosana; Kohler, Alejandro Alfredo
(Wolters Kluwer Health, 2022-08-31)
Objetive: Rituximab (RTX) is a therapeutic option, for patients with myasthenia gravis (MG) not responding to conventional immunosuppressive treatment. In this cohort, we evaluated long-term efficacy of RTX in the treatment ...